Clinical Trial: 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508852) titled '68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer' on March 21.

Brief Summary: This study aims to investigate and evaluate the safety and performance of a novel probe, PFD3, for the diagnosis and assessment of patients with small cell lung cancer (SCLC).

Study Start Date: June 01, 2025

Study Type: INTERVENTIONAL

Condition: SCLC SCLC, Extensive Stage SCLC, Limited Stage Small Cell Lung Cancer Small Cell Lung Cancer ( SCLC )

Intervention: DIAGNOSTIC_TEST: Sequential [18F]-FDG PET/CT

Based on individual clinical circumstances, eligible patients will undergo sequential [18F]FDG PET/CT and [68Ga]Ga-P...